Ronald C. Renaud JR

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Allison Ambrose, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald C. Renaud JR:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atara Biotherapeutics, Inc. Director Common Stock 31,500 $12,254 $0.3890 23 Jun 2022 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Common Stock 0 $0 $41.18 01 Aug 2024 By Trust
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Performance-based Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
Atara Biotherapeutics, Inc. Director Non-Qualified Stock Option (Right to Buy) 31,500 23 Jun 2022 Direct
Upstream Bio, Inc. Director Stock Option (Right to Buy) 17,096 10 Jun 2025 Direct
Ikena Oncology, Inc. Director Stock Option (Right to Buy) 13,419 09 Jun 2022 Direct
Cerevel Therapeutics Holdings, Inc. President & CEO, Director Stock Option (Right to Buy) 0 01 Aug 2024 Direct
Translate Bio, Inc. Chief Executive Officer, Director Common Stock 0 14 Sep 2021 By Ronald C. Renaud, Jr. Trust - 2007
Translate Bio, Inc. Chief Executive Officer, Director Common Stock 0 14 Sep 2021 By Ronald Renaud 2014 Irrevocable Family Trust
Translate Bio, Inc. Chief Executive Officer, Director Common Stock 0 14 Sep 2021 Direct
Translate Bio, Inc. Chief Executive Officer, Director Stcok Option (right to buy) 0 14 Sep 2021 Direct
Translate Bio, Inc. Chief Executive Officer, Director Stock Option (right to buy) 0 14 Sep 2021 Direct

Insider Reports Filed by Ronald C. Renaud JR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
UPB Upstream Bio, Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:17
UPB Upstream Bio, Inc. 10 Oct 2024 1 $0 4 Director 15 Oct 2024, 16:15
UPB Upstream Bio, Inc. 10 Oct 2024 0 $0 3 Director 10 Oct 2024, 20:09
/report/000095017024090851-renaud-ronald-c-jr-2024-08-01 Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 5 $0 4 President & CEO, Director 05 Aug 2024, 16:36
/report/000095017024006667-renaud-ronald-c-jr-2024-01-19 Cerevel Therapeutics Holdings, Inc. 19 Jan 2024 1 $0 4 President & CEO, Director 23 Jan 2024, 17:31
/report/000095017023072374-renaud-ronald-c-jr-2023-12-19 Cerevel Therapeutics Holdings, Inc. 19 Dec 2023 2 $0 4 President & CEO, Director 21 Dec 2023, 20:18
/report/000095017023039169-renaud-ronald-c-jr-2023-08-03 Cerevel Therapeutics Holdings, Inc. 03 Aug 2023 1 +$2,008,811 4 President & CEO, Director 07 Aug 2023, 17:13
/report/000089924323015539-renaud-ronald-c-jr-2023-06-12 Cerevel Therapeutics Holdings, Inc. 12 Jun 2023 3 $0 4 President & CEO, Director 14 Jun 2023, 16:53
/report/000089924323015536-renaud-ronald-c-jr-2023-06-12 Cerevel Therapeutics Holdings, Inc. 12 Jun 2023 0 $0 3 President & CEO, Director 14 Jun 2023, 16:49
ATRA Atara Biotherapeutics, Inc. 23 Jun 2022 2 $0 4 Director 27 Jun 2022, 16:48
IKNA Ikena Oncology, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:09
IKNA Ikena Oncology, Inc. 21 Dec 2021 1 $0 4 Director 23 Dec 2021, 17:35
/report/000120919121056062-renaud-ronald-c-jr-2021-09-14 Translate Bio, Inc. 14 Sep 2021 8 -$36,254,014 4 Chief Executive Officer, Director 14 Sep 2021, 19:32
ATRA Atara Biotherapeutics, Inc. 08 Jun 2021 2 $0 4 Director 09 Jun 2021, 19:13
/report/000120919121056060-renaud-ronald-c-jr-2021-04-07-restatement Translate Bio, Inc. 07 Apr 2021 2 +$66,702 4/A Chief Executive Officer, Director 14 Sep 2021, 19:31